1987
DOI: 10.1016/0021-9150(87)90004-9
|View full text |Cite
|
Sign up to set email alerts
|

Apolipoprotein E polymorphism, serum lipids and occurrence of ‘double pre-betalipoproteinemia’ (DPBL) in subjects from two different populations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
3
0

Year Published

1987
1987
2004
2004

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 32 publications
2
3
0
Order By: Relevance
“…Our data and those of Pagnan et al (45) suggest that this view may need to be reevaluated. As reported by others (9,46) and confirmed here, the concentration of apo E in blood plasma tends to be lower in subjects with an ⑀4 allele than in ⑀3 homozygotes, and a larger fraction of apo E is found in VLDL and less in HDL from subjects with an ⑀4 allele.…”
Section: Discussionsupporting
confidence: 46%
See 2 more Smart Citations
“…Our data and those of Pagnan et al (45) suggest that this view may need to be reevaluated. As reported by others (9,46) and confirmed here, the concentration of apo E in blood plasma tends to be lower in subjects with an ⑀4 allele than in ⑀3 homozygotes, and a larger fraction of apo E is found in VLDL and less in HDL from subjects with an ⑀4 allele.…”
Section: Discussionsupporting
confidence: 46%
“…To our knowledge, the postprandial response of apo B100-containing TRL in individuals with an ⑀4 allele has not been reported previously. It is noteworthy, however, that "double prebetalipoproteinemia," which is characterized by the accumulation of remnant-like VLDL in postabsorptive plasma (24), has been found to be significantly more prevalent in normolipidemic Finns and hyperlipidemic Italians with apo E4/4 and E4/3 phenotypes than in those with an apo E3/3 phenotype (45). The combined data from the two populations showed that double prebetalipoproteinemia occurred in 34 out of 56 individuals (61%) with phenotypes E4/3 and E4/4, but only in 31 out of 117 individuals (27%) with phenotype E3/3.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In contrast, expression of apoE2, which also markedly increased hepatic VLDL-TG production, resulted in a highly significant increase in plasma triglyceride levels 3 days after vector administration, probably due to the fact that clearance of TG-rich VLDL was relatively impaired compared with apoE3. Expression of apoE4 resulted in a significantly greater increase in plasma triglycerides on day 3 compared with apoE3, consistent with the findings that humans with at least one apoE4 allele have increased plasma VLDL remnants (11) and delayed clearance of remnant lipoproteins (12), and that mice expressing apoE4 have reduced VLDL catabolism compared with mice expressing apoE3 (13).…”
Section: Discussionsupporting
confidence: 84%
“…Mean serum total cholesterol levels also tended to be higher in the apo E3/4 phenotype group than in the apo E3/3 phenotype group, though the difference was not quite significant at the 5~ level probably due to small sample sizes. It has been demonstrated that mean serum total cholesterol levels have a tendency to be higher in the apo E3/4 phenotype as compared with the apo E3/3 phenotype in Caucasians (Sing and Davignon, 1985;Boerwinkle et al, 1987;Pagnan et al, 1987). Considering that most of multifactorial hypercholesterolemia is not severe and that many individuals with apo E4 are normocholesterolemic, these findings suggest that the apo E4 allele acts as a polymeric gene in predisposing one to hypercholesterolemia.…”
Section: Discussionmentioning
confidence: 99%